Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 10 of 23
Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy
NCT04658784
Integrated Intervention for Caregivers--Open Trial
NCT03487575
Incorporating Nutrition, Vests, Education, and Strength Training in Bone Health (INVEST in Bone Health)
NCT04076618
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage
NCT04088630
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
NCT04173247
SNIFF Multi-Device Study 2
NCT04199767
Stay In Treatment for Pediatric Weight Management
NCT04364282
Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship
NCT04495946
Permanent Versus Delayed-Absorbable Monofilament Suture
NCT04506177
VR System for Cross-modal Rehabilitation of Hemianopia
NCT04230486
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
NCT04156802
Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19
NCT04547283
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
NCT04154111
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
NCT04187196
Evaluation of a Personalized Care Management Program for High Hospital Utilizers
NCT04727567
Precision Medicine for Patients With Identified Actionable Mutations
NCT04111107
COVID-19 Community Research Partnership
NCT04342884
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
NCT04022980
Mindfulness During COVID-19
NCT04319445
Computational Psychiatric Approach to Depression
NCT04189939
Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants
NCT03845894
A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus (Feasibility)
NCT03811743
Rural Survivorship Navigation Program
NCT03880526
TENS and Perioperative Fracture Patients
NCT04209673
Nurse Initiated Acupressure for Pain Management
NCT04044716
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
NCT03958747
EMR Outcomes: Anxiety and Depression in Epilepsy
NCT03879525
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
NCT04040244
Evaluation of Extubation Criteria in Children With Upper Respiratory Infection (URI)
NCT04155892
Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis , Full Scale Trial
NCT04194164
Amnion Wound Covering for Enhanced Wound Healing
NCT03754218
Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol
NCT04151199
Clinician Burnout and Social Determinants
NCT04070456
Using Music During Lumbar Medial Branch Block Procedure
NCT04091607
Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?
NCT04124939
ICOLLAB FOR Children With Medical Complexity
NCT03978468
Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma
NCT03870451
Effectiveness and Implementation of mPATH-CRC
NCT03843957
Exercise Training and Metabolic Flexibility in Prediabetes
NCT04051229
Effects of Intramuscular (IM) Oxytocin on Pupil Diameter and Heart Rate Variability (HRV)
NCT04105998
Bioenergetic Profiling and Cognition in GBM Patients
NCT03939858
A Virtual Navigation Intervention to Reduce Behavioral Health Admissions From Rural Emergency Departments
NCT04148521
Metabolic and Microbial Profiling of Lung Cancer
NCT03998189
Angiotensin II in General Anesthesia
NCT03733145
Opioid Free Management After Ureteroscopy
NCT03872843
High-Resolution Anoscopy Perceived Discomfort Study
NCT04083053
Emission Patterns of Respiratory Syncytial Virus
NCT03909867
Pragmatic Investigation of Volume Targeted Ventilation-1
NCT03909854
DHS MIND Metabolomics
NCT03975309
Molecular Transducers of Physical Activity Consortium
NCT03960827
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.